0.048 (6.29%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Weak
Earnings
Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Neurosense Therapeutics Ltd.
Telephone
972.9.799.6183
Address
Building B, 11 HaMenofim Street, Herzliya, Tel Aviv 4672562
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.63 - 2.6
Trade Value (12mth)
US$115,468.00
1 week
-7.82%
1 month
10.43%
YTD
-2.3%
1 year
-49.2%
All time high
8.18
EPS 3 yr Growth
-59.30%
EBITDA Margin
0.00%
Operating Cashflow
-$8m
Free Cash Flow Return
NaN%
ROIC
NaN%
Interest Coverage
NaN
Quick Ratio
0.30
Shares Outstanding (Fully Diluted)
25m
HALO Sector
Healthcare
Next Company Report Date
08-Apr-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 29 April 26 | |
| 24 April 26 | |
| 06 April 26 | |
| 04 April 26 | |
| 04 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.74 | -0.55 | -0.44 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.74 | -0.55 | -0.44 | | | | ||
Growth | % | | | | | 30.9 | 25.9 | 20.5 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
